Loading clinical trials...

Evaluation of Tolsura When Used as Prophylaxis After Lung Transplantation | Clinical Trials | Clareo Health

WITHDRAWN

Evaluation of Tolsura When Used as Prophylaxis After Lung Transplantation

NCT04652050•Hong Nguyen

View on ClinicalTrials.gov

Summary

This is a single-center, observational study of Tolsura PK sampling in lung transplant recipients

Detailed Description

Patients who are receiving Tolsura as part of their clinical care will be asked to enroll and EMR data and excess biological samples will be collected

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•18 years of age and older
•hospitalized at UPMC
•placed on Tolsura prophylactically by clinical team
•patients who have had or will have a lung transplant.

Exclusion Criteria

•redo lung transplant
•recipient with dual liver-lung transplant
•patients with previous history of SOT
•including other organ transplantation
•patients with known pre-transplant colonization with moulds resistant to azoles
•patients with intra-transplant positive cultures for moulds in either transplant recipient or his/her donor
•patients with a history of hypersensitivity reaction to an azole agent
•patients who are kept NPO (nothing by mouth, including meds)
•recipients or donor with HepC PCR positive

Locations (1)

UPMC

Pittsburgh, Pennsylvania, United States

Key Dates

Start Date

December 1, 2020

Primary Completion Date

April 1, 2023

Completion Date

April 1, 2023

Last Updated

April 24, 2023

Conditions

Lung Transplant Infection

Interventions

Tolsura

DRUG

Liquid biopsiEs fOr luNg AllogRaft Damage classificatiOn - LEONARDO

NCT06679257

Lung Transplant Failure and RejectionLung Transplant Infection

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 24, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions